Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1964 1
1965 2
1966 1
1967 1
1971 1
1973 2
1974 2
1975 5
1976 1
1978 1
1979 2
1980 1
1984 2
1985 3
1986 2
1987 6
1988 2
1990 3
1991 1
1992 3
1993 4
1994 2
1995 5
1996 5
1997 6
1998 6
1999 2
2000 11
2001 3
2002 8
2003 9
2004 9
2005 17
2006 11
2007 8
2008 13
2009 22
2010 23
2011 21
2012 23
2013 24
2014 32
2015 49
2016 38
2017 28
2018 24
2019 27
2020 33
2021 36
2022 45
2023 32
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

572 results

Results by year

Filters applied: . Clear all
Page 1
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: pai ps. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.
D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R; Head and Neck Disease Management Group. D'Cruz AK, et al. Among authors: pai p. N Engl J Med. 2015 Aug 6;373(6):521-9. doi: 10.1056/NEJMoa1506007. Epub 2015 May 31. N Engl J Med. 2015. PMID: 26027881 Free article. Clinical Trial.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: pai ps. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, Pai PS, Chaturvedi P, Chaukar D, Pande N, Chandrasekharan A, Talreja V, Vallathol DH, Mathrudev V, Manjrekar A, Maske K, Bhelekar AS, Nawale K, Kannan S, Gota V, Bhattacharjee A, Kane S, Juvekar SL, Prabhash K. Noronha V, et al. Among authors: pai ps. J Clin Oncol. 2018 Apr 10;36(11):1064-1072. doi: 10.1200/JCO.2017.74.9457. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220295 Clinical Trial.
A Review on Microfluidics-Based Impedance Biosensors.
Chen YS, Huang CH, Pai PC, Seo J, Lei KF. Chen YS, et al. Among authors: pai pc. Biosensors (Basel). 2023 Jan 3;13(1):83. doi: 10.3390/bios13010083. Biosensors (Basel). 2023. PMID: 36671918 Free PMC article. Review.
Myelitis in systemic lupus erythematosus.
Li XY, Xiao HB, Pai P. Li XY, et al. Among authors: pai p. J Clin Neurosci. 2017 Oct;44:18-22. doi: 10.1016/j.jocn.2017.06.003. Epub 2017 Jul 8. J Clin Neurosci. 2017. PMID: 28694045 Review.
Bleeding Risk in Hemodialysis Patients.
van Eck van der Sluijs A, Pai P, Zhu W, Ocak G. van Eck van der Sluijs A, et al. Among authors: pai p. Semin Nephrol. 2024 Jan 17:151478. doi: 10.1016/j.semnephrol.2023.151478. Online ahead of print. Semin Nephrol. 2024. PMID: 38238225 Review.
The role of histone deacetylases in embryonic development.
Dsilva P, Pai P, Shetty MG, Babitha KS. Dsilva P, et al. Among authors: pai p. Mol Reprod Dev. 2023 Jan;90(1):14-26. doi: 10.1002/mrd.23659. Epub 2022 Dec 19. Mol Reprod Dev. 2023. PMID: 36534913 Review.
Transoral thyroidectomy- Breaking new grounds??
Pai PS. Pai PS. J Postgrad Med. 2019 Apr-Jun;65(2):72-73. doi: 10.4103/jpgm.JPGM_91_19. J Postgrad Med. 2019. PMID: 31036777 Free PMC article. No abstract available.
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-Analysis.
Rao KN, Pai PS, Dange P, Kowalski LP, Strojan P, Mäkitie AA, Guntinas-Lichius O, Robbins KT, Rodrigo JP, Eisbruch A, Takes RP, de Bree R, Coca-Pelaz A, Piazza C, Chiesa-Estomba C, López F, Saba NF, Rinaldo A, Ferlito A. Rao KN, et al. Among authors: pai ps. Biomedicines. 2023 Jul 28;11(8):2128. doi: 10.3390/biomedicines11082128. Biomedicines. 2023. PMID: 37626625 Free PMC article. Review.
572 results